+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Fundamentals of Brain Organoids for Neurological Diseases

  • Book

  • September 2025
  • Elsevier Science and Technology
  • ID: 6042212
Fundamentals of Brain Organoids for Neurological Diseases provides a practical resource for researchers on how to utilize and apply brain organoids. This book is organized into nine distinct sections, guiding the reader through each step from advanced overview of what organoids are to the use of brain organoids in various neurodevelopmental disorders and neurodegenerative diseases. In later sections, this book reviews the necessary methods involved in organoid development including the elements and challenges involved. This book will serve as a valuable tool for researchers, helping to advance the understanding of brain biology and disease mechanisms.

Researchers use brain organoids to study the formation of neural tissues, investigate the processes involved in brain development, and gain a better understanding of neurological disorders and diseases. Brain organoids are particularly useful in studying developmental disorders, neurodegenerative diseases, and infectious diseases that affect the brain.

Table of Contents

Section I An overview about Organoids
1. What are organoids?
2. Past, Present and Future scenario of organoids

Section II Neurological diseases
3. A brief introduction about Neurodevelopmental disorders
4. An overview of Neurodegenerative diseases

Section III Brain organoids for Neurodevelopmental disorders
5. Use of brain organoids for Autism
6. Role of brain organoids in Rett Syndrome
7. Role of brain organoids in Bipolar disorder

Section IV Brain organoids for Neurodegenerative diseases
8. Use of brain organoids for Parkinson’s disease (PD)
9. Role of brain organoids in Alzheimer’s disease (AD)
10. Application of brain organoids in Huntington’s disease (HD)

Section V Methods involved in organoids development
11. How HiPSCs are derived into organoids
12. Elements required for organoid generation
13. Days involved in organoid generation
14. Challenges while constructing organoids

Section VI Ongoing Clinical trials
15. Ongoing clinical trials on use of Brain organoids for neurodevelopmental disorders
16. Ongoing clinical trials on use of Brain organoids for neurodegenerative diseases

Section VII Application and advancement of Brain organoids
17. Brain organoids A promising disease model
18. Existing drug targeting using Brain organoids
19. New drug research by brain organoids

Section VII Ethical consideration while conducting organoids research

Section IX Future Direction and Conclusion

Authors

Balachandar Vellingiri Central University of Punjab, India. Dr. Balachandar Vellingiri is mainly working on neurological diseases and analyzing its genetic impact. He is working on to develop human induced pluripotent stem cells (HiPSCs) and to generate patient derived Brain organoids as a promising disease model for various neurological disease because understanding the inside mechanism of neurological diseases is always a difficult task. He is well-expertise in techniques such as molecular cytogenetics, sequencing, techniques in developing HiPSCs and Brain organoids especially for neurodegenerative disease like Parkinson's disease. He has published more than 100 research and review articles in various Internationally reputed SCI journals and 3 Book chapters and 1 book on Autism Spectrum Disorder. To his credit Dr. Balachandar Vellingiri has received a Prime Minister Funded Project Called ? Indo-Japan Collaborative Project under Prof. Shinya Yamanaka (Nobel Laureate - Father of Induced Pluripotent Stem Cell, Center for iPS Cell Research and Application (CiRA), Kyoto University, Japan, November 2017. Further, he has been awarded with the most prestigious award from Tamil Nadu government "Tamil Nadu Young Scientist� award from Ministry of Higher Education, Science City, Tamil Nadu Government, February 2017. Mahalaxmi Balachandar Karpagam Academy of Higher Education, India. Dr. Mahalaxmi Balachandar have the experience of handling neurological disorder patients and have conducted few genetic and epigenetic studies. She had a one-year experience of handling the bone-marrow derived mesenchymal stem cells (BM-MSCs) as a promising therapeutic agent for LHON disease. Further Dr. Mahalaxmi Balachandar has generated the Brain organpoids from various neurodevelopmental diseases. She had published almost around 50 review and research articles in several International reputed SCI journals. To her credit, she has been awarded with several national funding agencies like Department of Biotechnology - Research Assocaite (DBT-RA) fellow. Also, she was awarded as the Gold Medalist for her PhD Thesis.